The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 11, 1996, Pages 687-692

  Pietilainen T ^a   Lipponen, P ^a   Aaltomaa, S ^a   Eskelinen, M ^a   Kosma, V M ^a   Syrjanen K ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Breast cancer; Cell proliferation; Image analysis; Ki 67; Prognosis

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0029861983     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01209033     Document Type: Article

References (31)

1. Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E Syrjanen K (1991) Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer. Int J Cancer 49:886-892
2. Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E Syrjanen K (1992) Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol 118:75-81
3. Beck T, Weller EE, Brumm C, Wilkens C, Knapstein PG (1995) Usefullness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognostic parameters and with the proliferation marker, MIB-1. Gynecol Oncol 57:96-104
4. Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377
5. Bouzubar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JF, Blarney RW, Nicholson RI (1989) Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59:943-947
6. Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17:489-503
7. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen(MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363
8. Chauvel P, Courdi A, Gioanni J, Vallicinoi J, Santini J, Demard F (1989) The labelling index: a prognostic factor in head and neck carcinoma. Radiother Oncol 14:231-237
9. Eskelinen M, Lipponen P. Papinaho S, Aaltomaa S, Kosma VM, Klemi P, Syrjanen K (1992) DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer. Int J Cancer 51:555-561
10. Gasparini G, Boracchi P, Verderio P, Bevilacqua P (1994) Cell kinetics in human brest cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry. Int J Cancer 57:822-829
11. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
12. Huovinen R, Collany (1994) Cell loss in dimethylbenz(a)anthracene-induced rat mammary carcinoma treated with toremifene and ovariectomy. Tumor Biol 15:345-353
13. Isola J, Visakorpi T, Holli K, Kallioniemi OP (1992) Association of overexpression of tumour suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84:1109-1114
14. Jensen EV (1991) Steroid hormone receptors. Curr Top Pathol 83:365-431
15. Kennedy JC, Badawy N, el, DeRose PB, Cohen C (1992) Comparison of cell prolifration in breast carcinoma using image analysis (Ki-67) and flow cytometric systems. Anal Quant Cytol Histol 14:304-311
16. Kerr JF, Winterford CM, Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73:2013-2026
17. Lee E, Lesu M (1972) A computer program for comparing k samples with right censored data. Comput Prog Biomed 2:315-320
18. Liotta LA (1992) Cancer cell invasion and metastasis. Sci Am 266 : 54-59, 62-63
19. Martinazzi M, Crivelli F, Zampatti C, Martinazzi S (1993) Relationship between p53 expression and other progonostic factors in human breast carcinoma. An immunohistochemical study. Am J Clin Pathol 100:213-217
20. Pavelic ZP, Pavelic L, Lower EE, Gapany M, Gapany S, Barker EA Preisler HD (1992) c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvassive breast carcinoma. Cancer Res 52:2597-2602
21. Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K (1995) Expression of p53 protein has no independent prognostic value in breast cancer. J Pathol 177:225-232
22. Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JF, Blarney RW Ellis IO (1995) Assessment of the new proliferation marker MIBI in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 71:146-149
23. Railo M, Nordling S, von Boguslawsky K, Leivonen M, Kyllonen L, von Smitten K (1993) Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 68:579-583
24. Rudas M, Gnant MF, Mittlbock M, Neumayer R, Kummer A, Jakesz R, Reiner G, Reiner A (1994) Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis. Breast Cancer Res Treat 32:165-175
25. Schulte Hermann R, Grasl Kraupp B, Bursch W (1994) Tumour development and apoptosis. Int Arch Allergy Immunol 105:363-367
26. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U (1993) p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85:965-970
27. Steller H (1995) Mechanisms and genes of cellular suicide. Science 267:1145-1449
28. Vihko R, Jänne O, Kontula K, Syrjälä P (1980) Female sex steroid reseptor status in primary and metastatic breast carcinoma and its relationship to serum steroid and peptide hormone levels. Int J Can 26:13-21
29. Walker NI, Harmon BV, Gobe GC, Kerr JFR (1988) Patterns of cell death. Methods Achiev Exp Pathol 13:18-54
30. Weinder N, Moore DHI, Vartarian R (1994) Correlation of Ki-67 antigen expression with mitotic figure index and tumour grade in breast carcinoma using the novel "paraffin"-reactive MIBI antibody. Hum Pathol 25:337-342
31. WHO (1981) Histological typing of breast tumours. In: International histological classification of tumours. 2, 2nd ed. World Health Organization, Geneva